In Vitro Activities of 21 Antimicrobial Agents Alone and in Combination with Aminoglycosides or Fluoroquinolones against Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia

被引：18
|
作者：
Cha, Min Kyeong [1 ]
Kang, Cheol-In [2 ]
Kim, So Hyun [1 ,2 ]
Cho, Sun Young [2 ]
Ha, Young Eun [2 ]
Wi, Yu Mi [3 ]
Chung, Doo Ryeon [1 ,2 ]
Peck, Kyong Ran [2 ]
Song, Jae-Hoon [1 ,2 ]
机构：
[1] APFID, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Infect Dis, Chang Won, South Korea
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 09期
基金：
新加坡国家研究基金会;
关键词：
ANTIBIOTIC-THERAPY; MOLECULAR EPIDEMIOLOGY; SEPTIC SHOCK; RISK-FACTORS; INFECTIONS; SEPSIS; MONOTHERAPY; IMPACT;
D O I：
10.1128/AAC.01121-15
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We evaluated the in vitro activity of various antimicrobials alone and in combination against 291 extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) isolates causing bacteremia in South Korean hospitals. Ceftazidime, cefepime, and piperacillin-tazobactam in combination with amikacin showed greater activity than found in combination with ciprofloxacin. In settings with a high prevalence of ESBL-producing pathogens, combination aminoglycoside antimicrobial therapy, especially with amikacin, may be considered for empirical therapy against suspected Gram-negative sepsis as a carbapenem-saving strategy.
引用
收藏
页码：5834 / 5837
页数：4
相关论文
共 50 条
  • [21] Detection of OXA-2 group extended-spectrum-β-lactamase-producing clinical isolates of Escherichia coli from India
    Bhattacharjee, Amitabha
    Sen, Malay Ranjan
    Anupurba, Shampa
    Prakash, Pradyot
    Nath, Gopal
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (03) : 703 - 704
  • [22] In vitro activity of antimicrobial agents against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon
    Samaha-Kfoury, JN
    Kanj, SS
    Araj, GF
    AMERICAN JOURNAL OF INFECTION CONTROL, 2005, 33 (03) : 134 - 136
  • [23] Therapeutic Options for Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli
    Tarchini, Giorgio
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (01) : 119 - 120
  • [24] Activity of Cefepime in Combination with the Novel β-Lactamase Inhibitor Taniborbactam (VNRX-5133) against Extended-Spectrum-β-Lactamase-Producing Isolates in In Vitro Checkerboard Assays
    Kloezen, Wendy
    Melchers, Ria J.
    Georgiou, Panagiota-Christina
    Mouton, Johan W.
    Meletiadis, Joseph
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
  • [25] Decreased Susceptibility to Noncarbapenem Antimicrobials in Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Toronto, Canada
    Lowe, Christopher F.
    McGeer, Allison
    Muller, Matthew P.
    Katz, Kevin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3977 - 3980
  • [26] Activities of Fosfomycin, Tigecycline, Colistin, and Gentamicin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Foreign-Body Infection Model
    Corvec, Stephane
    Tafin, Ulrika Furustrand
    Betrisey, Bertrand
    Borens, Olivier
    Trampuz, Andrej
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (03) : 1421 - 1427
  • [27] Antibacterial effect of oregano essential oil alone and in combination with antibiotics against extended-spectrum β-lactamase-producing Escherichia coli
    Si, Hongbin
    Hu, Jinqiang
    Liu, Zhichang
    Zeng, Zhen-ling
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2008, 53 (02): : 190 - 194
  • [28] Bactericidal activities of meropenem and ertapenem against extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model
    DeRyke, C. Andrew
    Banevicius, Mary Anne
    Fan, Hong Wei
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1481 - 1486
  • [29] Duration of Stool Colonization in Healthy Medical Students with Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Li, Bin
    Zhong, Yang
    Fu, Xiao-chun
    Qiu, Yi-hui
    Wang, Si-Ying
    Yang, A-juan
    Huang, Xin-hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4558 - 4559
  • [30] Bloodstream infections caused by extended-spectrum-β-lactamase-producing Escherichia coli:: Risk factors for inadequate initial antimicrobial therapy
    Tumbarello, Mario
    Sali, Michela
    Trecarichi, Enrico Maria
    Leone, Fiammetta
    Rossi, Marianna
    Fiori, Barbara
    De Pascale, Gennaro
    D'Inzeo, Tiziana
    Sanguinetti, Maurizio
    Fadda, Giovanni
    Cauda, Roberto
    Spanu, Teresa
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (09) : 3244 - 3252
12345